ORS-ISFR 17th International Biennial Meeting

项目摘要 每年有超过2500万的美国人发生骨折，其中很大一部分骨折 无法治愈骨折进展延迟或愈合失败是导致患者残疾的主要原因 和成本。因此，迫切需要更好地了解骨愈合的生物学，并利用其 开发新的诊断和治疗方法的知识。我们正在寻求对第17届两年期会议的支持 国际骨折修复协会（International Section of Fracture Repair，ISFR）2017年，ISFR作为一个部分被纳入 矫形外科研究协会（ORS），从而利用最大的科学组织的推广， 致力于矫形外科研究。ISFR致力于促进和交流 最新的科学思想和研究成果，骨折修复及其应用，以改善 病人护理我们的使命是成为整合和展示与临床相关的前沿思想的首要论坛， 骨折愈合的转化和基础科学研究。组织主题是“跨学科 科学”，会议将集中在从细胞到病人规模的机械生物学的最新理解 及其在骨修复中的作用;器械开发的商业考虑因素和从实验室中转化想法 市场;以及个性化再生疗法和相关的先进技术（即，治疗学， 器官芯片，与免疫系统相互作用）。为了提高临床参与度， ISFR会议将在国际联合矫形研究学会（ICORS）第30届年会之前举行 周年纪念世界大会。ICORS世界大会计划由欧洲ORS（EORS）共同主办， 英国ORS（BORS）、AO研究院达沃斯。为了促进ISFR和 在这些协会中，我们会议的第二天（9月7日）被设计为临床桥梁日， ISFR和ICORS成员均可参加。总共，我们将有2个特邀主题演讲人，20个特邀会议 演讲人，以及15个选定摘要的讲台演讲。我们预计将有30-40篇摘要入选 作为海报。会议将介绍最新的研究骨折愈合基础生物学，翻译 研究和前瞻性临床研究。该计划委员会高度重视促进包容性 环境外科医生、生物学家、工程师和政策制定者将参加会议， 学术界政府和工业界各种活动将侧重于职业发展， 为骨愈合领域的受训者建立网络。

PROJECT SUMMARY Bone fractures occur in more than 25 million Americans per year, and a significant percentage of those fractures fail to heal. Fractures that show delayed or failed progression to heal account for the majority of patient disability and costs. Thus, there is an urgent need to better understand the biology of bone healing, and to use that knowledge to develop new diagnostics and therapeutics. We are seeking support for the 17th Biennial conference of the International Section of Fracture Repair (ISFR). In 2017, the ISFR was incorporated as a section within the Orthopaedic Research Society (ORS), thereby leveraging the outreach of the largest scientific organization in the world dedicated to orthopaedic research. The ISFR is dedicated to the advancement and exchange of the most current scientific ideas and research findings on fracture repair and its application to the improvement of patient care. Our mission is be the premier forum to integrate and present cutting-edge ideas related to clinical, translational, and basic science research of fracture healing. With an organizational theme of “Transdisciplinary Science”, sessions will focus on the newest understanding of mechanobiology from the cellular to patient scale and its role in bone repair; commercial considerations for device development and translating ideas from bench to market; and personalized regenerative therapies and associated advanced technologies (i.e., therapeutics, organ-on-a-chip, interplay with the immune system). In an effort to increase clinical participation, the Biennial ISFR Meeting will be held just prior to the International Combined Orthopaedic Research Societies (ICORS) 30th Anniversary World Congress. The ICORS World Congress program is co-hosted by the European ORS (EORS), British ORS (BORS), and AO Research Institute Davos. To catalyze cross-pollination between the ISFR and these societies, the second day of our meeting (September 7th) has been designed as a clinical bridge day where both ISFR and ICORS members can attend. In total, we will have 2 invited keynote speakers, 20 invited session speakers, and 15 abstract-selected podium presentations. We anticipate an additional 30-40 abstracts selected as posters. The meeting will present the most up to date research on fracture healing basic biology, translational research, and prospective clinical studies. The Program Committee is highly focused on fostering an inclusive environment. Surgeons, biologists, engineers, and policy makers will attend the meeting and be drawn from academia, government, and industry. A variety of activities will be focused on career development and networking for trainees in the bone healing field.